Larvol Delta - Alentis-Receives-FDA-Fast-Track-Designation-for-ALEP02-for-the-Treatment-of-CLDN1-Squamous-Solid-Tumors

ALE.P02 - Alentis Therap

https://www.businesswire.com/news/home/20241118754051/en/Alentis-Receives-FDA-Fast-Track-Designation-for-ALE.P02-for-the-Treatment-of-CLDN1-Squamous-Solid-Tumors

Nov 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next